12/19
07:00 am
clym
Climb Bio to be Added to the Nasdaq Biotechnology Index
Medium
Report
Climb Bio to be Added to the Nasdaq Biotechnology Index
12/3
07:55 am
clym
Climb Bio, Inc. (NASDAQ: CLYM) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
Low
Report
Climb Bio, Inc. (NASDAQ: CLYM) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
12/2
10:14 am
clym
Climb Bio, Inc. (NASDAQ: CLYM) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $10.00 price target on the stock.
Low
Report
Climb Bio, Inc. (NASDAQ: CLYM) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $10.00 price target on the stock.
11/12
04:05 pm
clym
Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights
Medium
Report
Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights
11/11
07:00 am
clym
Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the Board
Medium
Report
Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the Board
10/31
07:00 am
clym
Climb Bio to Present at Upcoming Investor Conferences
Medium
Report
Climb Bio to Present at Upcoming Investor Conferences
10/15
07:00 am
clym
Climb Bio to Provide Budoprutug Development Strategy and Corporate Update at Virtual Investor Event
Medium
Report
Climb Bio to Provide Budoprutug Development Strategy and Corporate Update at Virtual Investor Event
10/11
12:30 pm
clym
Climb Bio Announces Abstract Selected for Presentation at the American Society of Nephrology Kidney Week 2024
Low
Report
Climb Bio Announces Abstract Selected for Presentation at the American Society of Nephrology Kidney Week 2024
10/4
07:00 am
clym
Climb Bio to Present at William Blair’s Upcoming Conference Event on Transforming Autoimmune Diseases by Targeting CD19
Low
Report
Climb Bio to Present at William Blair’s Upcoming Conference Event on Transforming Autoimmune Diseases by Targeting CD19
10/3
10:00 am
clym
Climb Bio to Host Virtual Investor Event on October 15, 2024
Medium
Report
Climb Bio to Host Virtual Investor Event on October 15, 2024